Project

A Phase 1/2 Study of BMS-986408 Alone and in Combination with Nivolumab or with Nivolumab and Ipilimumab in Participants with Advanced Solid Tumors

Ongoing - recruitment active · 2023 until 2030

Jörger Markus, Hutter Franziska